Payer PolicyActive
Injectable Dermal Fillers and Bulking Agents – Commercial and Individual Exchange Medical Policyopen_in_new
UHC-POL-injectables-reconstructive-procedures
UnitedHealthcare
Effective: November 1, 2025
Updated: December 6, 2025
created · Nov 30, 2025
Policy Summary
UnitedHealthcare covers Radiesse and Sculptra as medically necessary reconstructive treatment for HIV-related facial lipoatrophy and covers FDA‑cleared injectable bulking agents for vocal fold insufficiency, while all other dermal fillers and non‑HIV uses of Radiesse/Sculptra are cosmetic and not medically necessary. Coverage requires use per FDA labeling and ALA guidance (including listed contraindications), is determined by the member’s specific benefit plan, and may require medical-record documentation to verify clinical criteria.
Coverage Criteria Preview
Key requirements from the full policy
"Radiesse and Sculptra are considered reconstructive and medically necessary for the treatment of facial defects due to facial lipoatrophy in individuals living with human immunodeficiency virus (HI..."
Sign up to see full coverage criteria, indications, and limitations.